Drug Information

Drug General Information
Drug ID
D0C1DG
Former ID
DNC005047
Drug Name
2-(Carbazole-9-sulfonyl)-benzoic acid
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527208]
Structure
Download
2D MOL

3D MOL
Formula
C19H13NO4S
Canonical SMILES
C1=CC=C2C(=C1)C3=CC=CC=C3N2S(=O)(=O)C4=CC=CC=C4C(=O)O
InChI
1S/C19H13NO4S/c21-19(22)15-9-3-6-12-18(15)25(23,24)20-16-10-4-1-7-13(16)14-8-2-5-11-17(14)20/h1-12H,(H,21,22)
InChIKey
WVHKYPINALNKJJ-UHFFFAOYSA-N
PubChem Compound ID
44393734
Target and Pathway
Target(s) Fatty acid-binding protein, adipocyte Target Info Inhibitor [527208]
Fatty acid-bindingprotein, epidermal Target Info Inhibitor [527208]
KEGG Pathway PPAR signaling pathwayhsa03320:PPAR signaling pathway
NetPath Pathway TCR Signaling PathwayNetPath_13:IL1 Signaling Pathway
Pathway Interaction Database AP-1 transcription factor network
Reactome Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis
Transcriptional regulation of white adipocyte differentiationR-HSA-163560:Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis
WikiPathways Lipid digestion, mobilization, and transport
Transcriptional Regulation of White Adipocyte Differentiation
References
Ref 527208Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target.
Ref 527208Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.